147 related articles for article (PubMed ID: 30974104)
1. A 3D bioprinted hydrogel mesh loaded with all-trans retinoic acid for treatment of glioblastoma.
Mirani B; Pagan E; Shojaei S; Duchscherer J; Toyota BD; Ghavami S; Akbari M
Eur J Pharmacol; 2019 Jul; 854():201-212. PubMed ID: 30974104
[TBL] [Abstract][Full Text] [Related]
2. Induction Therapy of Retinoic Acid with a Temozolomide-Loaded Gold Nanoparticle-Associated Ultrasound Effect on Glioblastoma Cancer Stem-Like Colonies.
Fadera S; Chen PY; Liu HL; Lee IC
ACS Appl Mater Interfaces; 2021 Jul; 13(28):32845-32855. PubMed ID: 34235925
[TBL] [Abstract][Full Text] [Related]
3. All-trans retinoic acid eluting poly(diol citrate) wafers for treatment of glioblastoma.
Jones T; Zhang B; Major S; Webb A
J Biomed Mater Res B Appl Biomater; 2020 Apr; 108(3):619-628. PubMed ID: 31087625
[TBL] [Abstract][Full Text] [Related]
4. In Vitro Glioblastoma Model on a Plate for Localized Drug Release Study from a 3D-Printed Drug-Eluted Hydrogel Mesh.
Chehri B; Liu K; Vaseghi G; Seyfoori A; Akbari M
Cells; 2024 Feb; 13(4):. PubMed ID: 38391976
[TBL] [Abstract][Full Text] [Related]
5. Quinacrine Mediated Sensitization of Glioblastoma (GBM) Cells to TRAIL through MMP-Sensitive PEG Hydrogel Carriers.
Erkoc P; Cingöz A; Onder TB; Kizilel S
Macromol Biosci; 2017 Feb; 17(2):. PubMed ID: 27762493
[TBL] [Abstract][Full Text] [Related]
6. Temozolomide-loaded photopolymerizable PEG-DMA-based hydrogel for the treatment of glioblastoma.
Fourniols T; Randolph LD; Staub A; Vanvarenberg K; Leprince JG; Préat V; des Rieux A; Danhier F
J Control Release; 2015 Jul; 210():95-104. PubMed ID: 25982679
[TBL] [Abstract][Full Text] [Related]
7. Targeting cancer stem cells in glioblastoma multiforme using mTOR inhibitors and the differentiating agent all-trans retinoic acid.
Friedman MD; Jeevan DS; Tobias M; Murali R; Jhanwar-Uniyal M
Oncol Rep; 2013 Oct; 30(4):1645-50. PubMed ID: 23877261
[TBL] [Abstract][Full Text] [Related]
8. All-trans retinoic acid modulates cancer stem cells of glioblastoma multiforme in an MAPK-dependent manner.
Karsy M; Albert L; Tobias ME; Murali R; Jhanwar-Uniyal M
Anticancer Res; 2010 Dec; 30(12):4915-20. PubMed ID: 21187470
[TBL] [Abstract][Full Text] [Related]
9. Enhanced targeting of invasive glioblastoma cells by peptide-functionalized gold nanorods in hydrogel-based 3D cultures.
Gonçalves DPN; Rodriguez RD; Kurth T; Bray LJ; Binner M; Jungnickel C; Gür FN; Poser SW; Schmidt TL; Zahn DRT; Androutsellis-Theotokis A; Schlierf M; Werner C
Acta Biomater; 2017 Aug; 58():12-25. PubMed ID: 28576716
[TBL] [Abstract][Full Text] [Related]
10. Bioengineered 3D brain tumor model to elucidate the effects of matrix stiffness on glioblastoma cell behavior using PEG-based hydrogels.
Wang C; Tong X; Yang F
Mol Pharm; 2014 Jul; 11(7):2115-25. PubMed ID: 24712441
[TBL] [Abstract][Full Text] [Related]
11. Post-resection treatment of glioblastoma with an injectable nanomedicine-loaded photopolymerizable hydrogel induces long-term survival.
Zhao M; Danhier F; Bastiancich C; Joudiou N; Ganipineni LP; Tsakiris N; Gallez B; Rieux AD; Jankovski A; Bianco J; Préat V
Int J Pharm; 2018 Sep; 548(1):522-529. PubMed ID: 30017818
[TBL] [Abstract][Full Text] [Related]
12. Temperature and pH-responsive in situ hydrogels of gelatin derivatives to prevent the reoccurrence of brain tumor.
Kang JH; Turabee MH; Lee DS; Kwon YJ; Ko YT
Biomed Pharmacother; 2021 Nov; 143():112144. PubMed ID: 34509823
[TBL] [Abstract][Full Text] [Related]
13. Bioprinting of glioma stem cells improves their endotheliogenic potential.
Wang X; Li X; Dai X; Zhang X; Zhang J; Xu T; Lan Q
Colloids Surf B Biointerfaces; 2018 Nov; 171():629-637. PubMed ID: 30107336
[TBL] [Abstract][Full Text] [Related]
14. Combination of all-trans retinoic acid and interferon-gamma upregulated p27(kip1) and down regulated CDK2 to cause cell cycle arrest leading to differentiation and apoptosis in human glioblastoma LN18 (PTEN-proficient) and U87MG (PTEN-deficient) cells.
Zhang R; Banik NL; Ray SK
Cancer Chemother Pharmacol; 2008 Aug; 62(3):407-16. PubMed ID: 17960384
[TBL] [Abstract][Full Text] [Related]
15. Combination of all-trans retinoic acid and interferon-gamma suppressed PI3K/Akt survival pathway in glioblastoma T98G cells whereas NF-kappaB survival signaling in glioblastoma U87MG cells for induction of apoptosis.
Zhang R; Banik NL; Ray SK
Neurochem Res; 2007 Dec; 32(12):2194-202. PubMed ID: 17616812
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-302b-inhibited E2F3 transcription factor is related to all trans retinoic acid-induced glioma cell apoptosis.
Chen PH; Shih CM; Chang WC; Cheng CH; Lin CW; Ho KH; Su PC; Chen KC
J Neurochem; 2014 Dec; 131(6):731-42. PubMed ID: 25040912
[TBL] [Abstract][Full Text] [Related]
17. Anticancer drug-loaded hydrogels as drug delivery systems for the local treatment of glioblastoma.
Bastiancich C; Danhier P; Préat V; Danhier F
J Control Release; 2016 Dec; 243():29-42. PubMed ID: 27693428
[TBL] [Abstract][Full Text] [Related]
18. 3D bioprinted glioma stem cells for brain tumor model and applications of drug susceptibility.
Dai X; Ma C; Lan Q; Xu T
Biofabrication; 2016 Oct; 8(4):045005. PubMed ID: 27725343
[TBL] [Abstract][Full Text] [Related]
19. 3D bioprinting of urethra with PCL/PLCL blend and dual autologous cells in fibrin hydrogel: An in vitro evaluation of biomimetic mechanical property and cell growth environment.
Zhang K; Fu Q; Yoo J; Chen X; Chandra P; Mo X; Song L; Atala A; Zhao W
Acta Biomater; 2017 Mar; 50():154-164. PubMed ID: 27940192
[TBL] [Abstract][Full Text] [Related]
20. Novel RGD containing, temozolomide-loading nanostructured lipid carriers for glioblastoma multiforme chemotherapy.
Song S; Mao G; Du J; Zhu X
Drug Deliv; 2016 May; 23(4):1404-8. PubMed ID: 26203687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
